Patricia Carr - 06 Mar 2024 Form 4 Insider Report for Jazz Pharmaceuticals plc (JAZZ)

Role: SVP, Chief Accounting Officer
Signature: By: /s/Adam Guttmann, as attorney in fact For: Patricia Carr
Issuer symbol: JAZZ
Transactions as of: 06 Mar 2024
Net transactions value: -$438,448
Form type: 4
Filing time: 08 Mar 2024, 18:07:30 UTC
Previous filing: 05 Mar 2024
Next filing: 11 Jun 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	JAZZ	Ordinary Shares	Sale	$149,371	-1,236	-12%	$120.85	9,064	06 Mar 2024	Direct	F1
transaction	JAZZ	Ordinary Shares	Sale	$82,257	-700	-7.7%	$117.51	8,364	06 Mar 2024	Direct	F1
transaction	JAZZ	Ordinary Shares	Sale	$206,821	-1,768	-21%	$116.98	6,596	07 Mar 2024	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
F2	Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $116.93 to $117.00. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

Content

Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.

Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $116.93 to $117.00. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.